What is the difference between a 503A pharmacy and a 503B outsourcing facility?

503A pharmacies typically prepare compounded medications pursuant to patient-specific prescriptions, while 503B outsourcing facilities are registered with the FDA and operate under a different federal regulatory framework that allows larger-scale preparation under applicable requirements.

What Is Compounded Semaglutide?

Written by Luma Meds Team

July 18, 2026 · 9 min read

A woman at her kitchen table having a telehealth video consultation with a pharmacist on her laptop, learning what compounded semaglutide is and how it is prescribed

If you've searched for semaglutide online, you've probably seen two different terms: brand-name semaglutide and compounded semaglutide.

Both may contain semaglutide as an active ingredient, but they are prepared and dispensed through different pharmaceutical pathways.

So what exactly does “compounded” mean?

Compounded semaglutide is a prescription medication prepared by a qualified compounding pharmacy or outsourcing facility to meet a patient's treatment needs, when permitted under applicable federal and state requirements. Unlike commercially manufactured medications such as Wegovy and Ozempic, compounded medications are prepared under a separate regulatory framework and are not individually reviewed and approved by the FDA before dispensing.

Here's what patients should understand.

What Does “Compounded” Mean?

Pharmaceutical compounding is the practice of preparing a medication to meet a patient's specific medical needs.

Compounding isn't unique to weight-loss medications.

For example, a healthcare provider might prescribe a compounded medication when a patient requires a particular dosage form, strength, or formulation that isn't available as a commercially manufactured product.

Depending on the circumstances, medications may be compounded by certain 503A pharmacies pursuant to patient-specific prescriptions or by registered 503B outsourcing facilities under a different federal regulatory framework.

Compounding pharmacies and outsourcing facilities operate under specific federal and state requirements, but compounded medications do not go through the same FDA premarket approval process as commercially manufactured drugs.

Two compounding pathways
	503A pharmacy	503B outsourcing facility
How it compounds	Patient-specific prescriptions	Larger-scale preparation under a separate federal framework
Registration	State-licensed pharmacy	Registered with the FDA as an outsourcing facility
Regulatory oversight	Primarily state boards of pharmacy	FDA oversight plus applicable federal requirements

Why Has Compounded Semaglutide Become So Common?

Demand for GLP-1 medications increased rapidly as semaglutide became widely used for diabetes and weight management.

During periods when FDA-approved semaglutide products were listed on the FDA Drug Shortages database, federal law provided circumstances under which eligible compounders could prepare certain compounded versions of commercially available medications, subject to applicable requirements.

This helped expand access to semaglutide-based treatment while supply was limited.

As availability of commercially manufactured products changes, compounding requirements may also change. Compounding pharmacies and healthcare providers must follow current federal and state requirements when determining whether a compounded medication may be prepared and prescribed.

Is Compounded Semaglutide FDA-Approved?

Compounded medications are not individually approved by the FDA in the same way as commercially manufactured medications.

This does not mean that compounding itself is prohibited. Compounding has an established role in healthcare and is recognized under federal law.

It means that compounded medications are prepared and regulated through a different pathway.

Commercially manufactured medications undergo FDA premarket review for safety, effectiveness, manufacturing, and quality. Compounded medications are prepared by qualified facilities under applicable compounding standards and requirements.

A different pathway — not an illegal one

Patients considering compounded semaglutide should receive treatment through an appropriately licensed healthcare provider and pharmacy and should have access to clear information about their prescription.

Does Compounded Semaglutide Contain the Same Active Ingredient?

Compounded semaglutide may be prepared using semaglutide as the active pharmaceutical ingredient.

Patients should review the medication information provided by their healthcare provider and dispensing pharmacy, including the formulation, concentration, instructions, and source of the medication.

Ask about salt forms

The FDA has issued guidance regarding certain semaglutide salt forms, including semaglutide sodium and semaglutide acetate. Patients should work with their healthcare provider and pharmacy to confirm that their prescription is prepared using an appropriate formulation and in accordance with applicable requirements.

What About Dosing?

Commercially manufactured semaglutide injections come in standardized products with specific dosing instructions.

Compounded semaglutide may be dispensed in a multidose vial or another format, depending on the pharmacy and prescription.

Concentrations may vary between prescriptions, so patients should use only the dosing instructions provided for their specific medication.

For example, the number of “units” shown on a syringe does not independently identify the amount of semaglutide being administered. The medication concentration and prescribed instructions are also needed.

Before using compounded semaglutide, patients should confirm:

The prescribed dose
The medication concentration
The correct syringe or measuring device
How often the medication should be administered
How the medication should be stored
Who to contact with dosing questions

Patients should follow the instructions provided by their healthcare provider and pharmacy rather than relying on information from another prescription or online source.

What Should Patients Look for in a Compounded Semaglutide Program?

A well-structured treatment program should provide clear information and ongoing support.

Before starting treatment, patients should understand:

Who is evaluating and prescribing the medication
Which pharmacy is filling the prescription
What formulation and concentration have been prescribed
How the medication should be measured and administered
How to store and handle the medication
How to contact their healthcare provider with questions or concerns
Whether follow-up care is available throughout treatment

Patients should feel comfortable asking questions about their prescription and should receive instructions that are easy to understand.

Have questions about your options?

Complete a short online intake. A licensed healthcare provider reviews your health history and determines whether treatment is appropriate — and explains exactly what you're prescribed and where it's filled.

Start your online visit

Compounded Doesn't Mean “The Same Thing for Less”

Compounded semaglutide is not simply a lower-cost version of a brand-name medication.

It is prepared through a different pharmaceutical process and may offer a treatment format, dosage, or care pathway that is appropriate for certain patients when prescribed by a licensed healthcare provider.

Commercially manufactured and compounded medications may differ in packaging, concentration, dosage forms, and dispensing instructions.

The most important considerations are whether the treatment is clinically appropriate, whether it is prescribed by a qualified healthcare provider, and whether it is prepared and dispensed through an appropriate pharmacy.

The Bottom Line

Compounded semaglutide is a prescription medication prepared through pharmaceutical compounding when permitted under applicable federal and state requirements.

It is prepared by a qualified pharmacy or outsourcing facility to support individualized treatment needs and is prescribed following an evaluation by a licensed healthcare provider.

Compounding has an established role in healthcare, and patients should receive clear information about their medication, dosing instructions, pharmacy, and follow-up care.

At Luma Meds, prescription treatment is provided following an evaluation by a licensed healthcare provider. Medication availability and treatment options depend on clinical appropriateness and applicable state and federal requirements.

Sources & further reading

U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” FDA information explaining pharmaceutical compounding, the regulatory framework for compounded drugs, and how compounded medications differ from commercially manufactured products.
U.S. Food and Drug Administration. “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” FDA guidance and updates regarding semaglutide availability and compounding requirements.
U.S. Food and Drug Administration. “FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” FDA information discussing compounded semaglutide, dosing considerations, product quality, and semaglutide formulations.
U.S. Food and Drug Administration. “Compounding When Drugs Are on FDA's Drug Shortages List.” FDA information explaining circumstances under which certain compounded medications may be prepared during drug shortages.

This article is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Individual treatment decisions should be made with a licensed healthcare provider.

Share this article

Weight Loss